Literature DB >> 9915195

Controversies in the management of inferior turbinate hypertrophy: a comprehensive review.

L E Jackson1, R J Koch.   

Abstract

Nasal obstruction must frequently be addressed during functional rhinoplasty. Even after a properly performed septorhinoplasty correcting septal deflection and/or nasal valve collapse, nasal obstruction may persist due to turbinate hypertrophy. Turbinates have many important functions, including warming and humidification of inspired air, and numerous factors can contribute to pathologic enlargement. Management of inferior turbinate hypertrophy has been actively debated for more than a century. The primary goal of therapy is to maximize the nasal airway for as extended a period as possible while minimizing complications of therapy, such as nasal drying and hemorrhage. This review describes the various medical and surgical therapeutic modalities widely used today, with emphasis placed on surgical management of the inferior turbinates. Advantages, disadvantages, complications, and controversies of each form of treatment are reviewed and discussed. A staged protocol of increasingly invasive interventions is proposed.

Entities:  

Mesh:

Year:  1999        PMID: 9915195     DOI: 10.1097/00006534-199901000-00049

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  23 in total

1.  Impact of Middle versus Inferior Total Turbinectomy on Nasal Aerodynamics.

Authors:  Anupriya Dayal; John S Rhee; Guilherme J M Garcia
Journal:  Otolaryngol Head Neck Surg       Date:  2016-05-10       Impact factor: 3.497

2.  The value of intranasal splints after partial inferior turbinectomy.

Authors:  Osama G Abdel-Naby Awad; Khalf A Hamid
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-11-04

3.  Investigating the effects of inferior turbinate outfracture on the lacrimal system by evaluating the results of paranasal sinus computed tomography and nasolacrimal irrigation test.

Authors:  Oğuzhan Dikici; Hafize Gökben Ulutaş; Gülçin Kazaz Dikici
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-09-19       Impact factor: 2.503

4.  The clinical value of the novel cauterization procedure for the inferior turbinate artery during turbinate surgery.

Authors:  Rasit Midilli; Sercan Gode; Bulent Karci; Mustafa Orhan; Canan Y Saylam
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-02       Impact factor: 2.503

5.  Identifying patients who may benefit from inferior turbinate reduction using computer simulations.

Authors:  Benjamin M Hariri; John S Rhee; Guilherme J M Garcia
Journal:  Laryngoscope       Date:  2015-05-11       Impact factor: 3.325

6.  Long-term efficacy of radiofrequency treatment of turbinate hypertrophy: a patient based point of view.

Authors:  Cinzia Incandela; Giuseppe Calamusa; Maria Fatima Massenti; Salvatore Incandela; Riccardo Speciale; Emanuele Amodio
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-11-27

7.  Comparison of submucosal resection and radiofrequency turbinate volume reduction for inferior turbinate hypertrophy: evaluation by magnetic resonance imaging.

Authors:  Can Ercan; Abdulkadir Imre; Ercan Pinar; Nezahat Erdoğan; E Umut Sakarya; Semih Oncel
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-12-03

Review 8.  Clinical and pathogenetic characteristics of pregnancy rhinitis.

Authors:  Eva K Ellegård
Journal:  Clin Rev Allergy Immunol       Date:  2004-06       Impact factor: 8.667

9.  Effect of nasal packing and haemostatic septal suture on mucociliary activity after septoplasty: an assessment by rhinoscintigraphy.

Authors:  Mustafa Kula; Imdat Yuce; Yasar Unlu; Ahmet Tutus; Sedat Cagli; Ibrahim Ketenci
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-10-13       Impact factor: 2.503

10.  The Impact of Middle Turbinate Concha Bullosa on the Severity of Inferior Turbinate Hypertrophy in Patients with a Deviated Nasal Septum.

Authors:  C M Tomblinson; M-R Cheng; D Lal; J M Hoxworth
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-03       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.